Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Genentech Announces Positive Interim Results for Emicizumab in Phase III Study of Children with Hemo

americanpharmaceuticalreviewApril 18, 2017

Tag: Genentech , Hemophilia A

PharmaSources Customer Service